Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-10

FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

The FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen from Amneal Pharmaceuticals of New York LLC under the ANDA program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCODONE BITARTRATE AND ACETAMINOPHEN (Hydrocodone bitartrate and acetaminophen)

Snippet

SUPPL AP for HYDROCODONE BITARTRATE AND ACETAMINOPHEN (HYDROCODONE BITARTRATE AND ACETAMINOPHEN)